Company: RNGE
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024206
Chunk: 127

Company: RANGE IMPACT, INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 127
---
 efforts to obtain information about the
customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA
believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA
requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit an investor’s
ability to buy and sell our common stock and could have an adverse effect on the market for our shares.

If
we issue and sell additional shares of our common stock in the future, our existing stockholders will be diluted and our stock price
could fall.

Our
articles of incorporation authorize the issuance of up to 1,000,000,000 shares of common stock, of which, as of June 30, 2025, 108,616,078
shares were outstanding and 18,855,879 shares were reserved for issuance under our stock incentive plan and other outstanding options
or warrants. As a result, we have a large number of shares of common stock that are authorized for issuance that are not outstanding
or otherwise reserved, and could be issued at the discretion of our Board of Directors. We expect to seek additional financing in the
future in order to fund our operations, and if we issue additional shares of common stock or securities convertible into common stock,
our existing stockholders will be diluted. Our Board of Directors may also choose to issue shares of our common stock or securities convertible
into or exercisable for our common stock to acquire assets or companies, for compensation to employees, officers, directors, consultants
and advisors, to fund capital expenditures and to enter into strategic partnerships. Additionally, shares of common stock could be issued
for anti-takeover purposes or to delay or prevent changes in control or management of the Company. Our Board of Directors may determine
to issue shares of our common stock on terms that our stockholders do not believe enhance stockholder value, or that may ultimately have
an adverse effect on our business or the trading price of our common stock. Further, the issuance of any such shares may cause further
dilution to the ownership interest of our current stockholders, reduce the book value per share of our common stock and may contribute
to a reduction in the market price for our common stock.

Our
principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters
subject to stockholder approval.

Certain
of our executive officers